Taiho Pharmaceutical Company Limited

Toshihiro Hamakawa

Setsuro Fujii

Kazuo Ogawa

Yoshiyuki Muranaka

Sadao Hashimoto

Takashi Suzue

Motoyoshi Kajihara

Toshiaki Shibata

A sulfonic acid ester derivative represented by the general formula ##STR1## wherein R.sub.1 is a hydrogen atom, alkyl having 1 to 4 carbon atoms or alkoxy having 1 to 4 carbon atoms, A is a group represented by the general formula ##STR2## (wherein R.sub.2 and R.sub.3 are each alkyl having 1 to 4 carbon atoms) or by the general formula ##STR3## (wherein R.sub.4 and R.sub.5 are each alkyl having 1 to 4 carbon atoms or, when taken together with the carbon atom to which they are attached, form cycloalkyl having 4 to 6 carbon atoms), and l is an integer of from 1 to 3, and a process for preparing the derivative.

Sulfonic acid ester derivatives and process for preparing same

Sulfonic acid ester derivatives useful as antilipemic agents

Novel sulfonate derivatives represented by the formula

Antilipemic and anti-inflammatory compositions containing sulfonate

A sulfonate derivative represented by the formula ##STR1## wherein R.sub.1 is lower alkyl, lower alkoxy or halogen, l is an integer of from 0 to 3, n is 0 or 1, A is straight-chain or branched-chain alkylene having 1 to 4 carbon atoms, and R.sub.2 is hydrogen or lower alkyl but, when n is 0 or 1 and A is straight-chain alkylene with 1 to 4 carbon atoms, is not hydrogen and the method for preparing the same.

Sulfonate derivatives, process for preparing same and antilipemic

Method of treating hyperlipidemia and inflammation with sulfonate

An oral antilipemic agent comprising a pharmaceutically effective amount of at least one of acidic polyamino acids having a molecular weight of 10,000 to 100,000 and pharmaceutically acceptable salts thereof, and an adjuvant.

Growing community of inventors

Naruto, Japan

Toshihiro Hamakawa